Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name PCAT6
   Synonyms PCAT6, KDM5B-AS1, PCAN-R1, ncRNA-a2, onco-lncRNA-96, ncRNA-a2, KDM5BAS1
   Region GRCh38_1:202810954-202812156    Sequence
   Ensembl ENSG00000228288
   RefSeq NR_046325
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name lung cancer
   ICD-0-3 C34  
   Methods qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc.
   Sample lung cancer tissues, cell lines (H292, PC-9, CL1-5, H460, H1650, A549, H446, and H1975)
   Expression Pattern up-regulated
   Function Description

PCAT6 expression was significantly elevated in lung cancer cells compared to normal human bronchial epithelial (NHBE) cells, especially in CL1-5 and H446 cells. PCAT6 knockdown significantly inhibited cellular proliferation and metastasis, as well as induced early apoptosis of lung cancer cells. Molecular analysis revealed that PCAT6 regulated the expression of two pivotal cancer-related proteins, c-Myc and p53, in lung cancer cells. However, PCAT6 was not directly combined with c-Myc and p53 as confirmed by RNA immunoprecipitation. Finally, a retrospective study further revealed that PCAT6 negatively correlates with overall survival of lung cancer patients.

   Pubmed ID 27458097
   Year 2016
   Title Knockdown of Long Noncoding RNA PCAT6 Inhibits Proliferation and Invasion in Lung Cancer Cells.
   External Links
   Links for  PCAT6 GenBank       HGNC       lncrnadb       Noncode
   Links for  lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.